Prathibha Shetty

Summary

Affiliation: Navi Mumbai
Country: India

Publications

  1. pmc Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells
    Prathibha Shetty
    Regenerative Medicine Group, Reliance Life Sciences Pvt Ltd, Navi Mumbai, India
    Asian J Transfus Sci 4:14-24. 2010
  2. ncbi request reprint Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells
    P Shetty
    Haematopoietic Stem Cell Group, Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre, R 282 TTC Industrial Area of MIDC, Thane Belapur Road, Rabale, Navi Mumbai 400 701, India
    Cell Biol Int 31:293-8. 2007
  3. doi request reprint Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease
    Prathibha Shetty
    Regenerative Medicine, Haematopoietic Stem Cell Group, Dhirubhai Ambani Life Sciences Centre, R 282 TTC Area of MIDC, Thane Belapur Road, Rabale, Navi Mumbai 400701, India
    Cell Biol Int 33:830-8. 2009
  4. doi request reprint Immunologic properties of human dermal fibroblasts
    Manisha Deshpande
    Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre, Maharashtra, India
    Hum Immunol 71:1089-98. 2010
  5. doi request reprint Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model
    Prathibha Shetty
    Regenerative Medicine, Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre R 282, TTC Industrial Area of MIDC, Thane Belapur Road, Rabale, Navi, Mumbai 400701, India
    Cell Biol Int 37:167-80. 2013

Collaborators

  • Ravindran Geeta
  • Manisha Deshpande
  • Deepa Ghosh
  • Shabari Tipnis
  • Anish Sen Majumdar
  • Chandra Viswanathan

Detail Information

Publications5

  1. pmc Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells
    Prathibha Shetty
    Regenerative Medicine Group, Reliance Life Sciences Pvt Ltd, Navi Mumbai, India
    Asian J Transfus Sci 4:14-24. 2010
    ..The purpose of this study is to explore the possibility of finding MSCs from a less controversial, easy, and abundant source, such as the umbilical cord, for potential regenerative medicine applications...
  2. ncbi request reprint Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells
    P Shetty
    Haematopoietic Stem Cell Group, Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre, R 282 TTC Industrial Area of MIDC, Thane Belapur Road, Rabale, Navi Mumbai 400 701, India
    Cell Biol Int 31:293-8. 2007
    ..Therefore, CBS can be used as an effective substitute to FBS for developing clinically useful protocols for culturing MSC...
  3. doi request reprint Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease
    Prathibha Shetty
    Regenerative Medicine, Haematopoietic Stem Cell Group, Dhirubhai Ambani Life Sciences Centre, R 282 TTC Area of MIDC, Thane Belapur Road, Rabale, Navi Mumbai 400701, India
    Cell Biol Int 33:830-8. 2009
    ..We have standardized the processing conditions for proliferation of BMMSCs using xenofree medium and checked their in vitro and in vivo neurogenic potential...
  4. doi request reprint Immunologic properties of human dermal fibroblasts
    Manisha Deshpande
    Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre, Maharashtra, India
    Hum Immunol 71:1089-98. 2010
    ..Interestingly, indoleamine dioxygenase, a molecule involved in immunosuppression, was also expressed in dermal fibroblasts in the absence of IFN-γ...
  5. doi request reprint Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model
    Prathibha Shetty
    Regenerative Medicine, Reliance Life Sciences Pvt Ltd, Dhirubhai Ambani Life Sciences Centre R 282, TTC Industrial Area of MIDC, Thane Belapur Road, Rabale, Navi, Mumbai 400701, India
    Cell Biol Int 37:167-80. 2013
    ..MSCs are less immunogenic and immunomodulatory, which opens up the further possibility of using these cells in allogeneic settings. This could be a novel cell therapy application, especially when getting autochthonous cells is difficult...